In issuing a positive recommendation, the EMA has diverged from the FDA, which has set higher approval standards for Moderna’s vaccine in the U.S.

SOUTH SAN FRANCISCO, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill ...

Topline data from 400-person sentinel cohort of the Phase 2b COVID-19 trial anticipated early Q2 2026Published positive clinical results in the ...

European regulators advanced several new medicines, including a combined flu and COVID vaccine and new treatments for rare diseases.

NEW YORK -- A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results ...

COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...

Pharmacists can prescribe the leading COVID-19 pill directly to patients under a new U.S. policy announced Wednesday that's intended to expand use of Pfizer's drug Paxlovid. The Food and Drug ...

CHICAGO -- Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release. The study will ...

Researchers at University of California San Diego School of Medicine have found that a natural fungal supplement taken at the ...

Pfizer announced on Wednesday that it has started clinical trials that could lead to the antiviral pill Paxlovid being available for children ages six and up to reduce the severity and duration of ...